WJCD  Vol.3 No.5 A , August 2013
First Results of ACH Cardioplegic Solution Clinical Application in Newborns and Infants under One Year of Age
ABSTRACT
Study objective involved comparison of two cardioplegic solutions: HTK-solution possessing high buffer capacity and a new ACH-solution with aminoacid buffer. Results revealed high cardioprotective efficiency during surgical repair of complex congenital heart disease both in the group that had received Custodiol and in the group that had received ACH-solution. Clinical and morphological parameters demonstrate high level of myocardial protection from intraoperative ischemia for single usage of ACH-solution during cardioplegic ischemia under 60 minutes in duration.

Cite this paper
Bockeria, L. , Boldyrev, A. , Kulaga, O. , Blejyants, G. , Egorov, D. , Popov, A. , Mumladze, K. , Egorova, I. , Artuhina, T. , Kalaeva, N. and Movsesian, R. (2013) First Results of ACH Cardioplegic Solution Clinical Application in Newborns and Infants under One Year of Age. World Journal of Cardiovascular Diseases, 3, 33-39. doi: 10.4236/wjcd.2013.35A006.
References
[1]   Cruz, D.N., Antonelli, M., Fumagalli, R., et al. (2009) Early use of polymyxin B hemoperfusion in abdominal septic shock. JAMA, 301, 2445-2452.

[2]   Reithmann, C., Reber, D., Kozlik-Feldmann, R., et al. (1997) A post-receptor defect of adenylyl cyclase in severely failing myocardium from children with congenital heart disease. European Journal of Pharmacology, 330, 79-86.

[3]   Ross, R.D. (2001) Grading the graders of congestive heart failure in children. Journal of Pediatrics, 138, 618-620.

 
 
Top